CellectGen’s mission is to develop user-friendly, saliva-based POC platform technologies to help dentists identify patients with high risk of emerging active disease lesions in less than 15 minutes. The screening test is as easy as 1-2-3, and unlike current clinical methods, it can be done by anyone from the comforts of home. The technology is based on integrated components consisting of: • Saliva collection • Lateral flow based test - Our next generation point-of-care testing technology allows for detection, and measurement of levels of specific biomarkers of bone and soft tissue destruction to estimate the status of active disease in patients. • Mobile application - Our mobile app quantifies results and guides treatment in real-time more accurately, more easily, and cost-effectively than current existing methods, thus permitting patients to save their natural teeth. The app will not only increase the accuracy of the test by quantifying the results and eliminating the dentist’s reliance on visual assessments, but also expand access to data and trends on each patient, digitally. Our products represent the next generation solutions, designed to improve early detection and prevention of dental implant failure and gum disease in the 64.7 million individuals who suffer from various forms of the disease